Simplex Trading, LLC Alkermes Plc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Simplex Trading, LLC holds 5,173 shares of ALKS stock, worth $153,379. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,173

Holding current value

$153,379

% of portfolio

0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$23.01 - $28.55 $119,030 - $147,689	5,173 New	5,173 $144,000
Q4 2023 Feb 02, 2024	SELL	$23.37 - $28.68 $350,339 - $429,941	-14,991 Reduced 62.48%	9,004 $249,000
Q3 2023 Nov 01, 2023	BUY	$27.17 - $31.97 $651,944 - $767,120	23,995 New	23,995 $672,000
Q4 2022 Feb 02, 2023	BUY	$21.94 - $26.24 $19,175 - $22,933	874 New	874 $22,000
Q2 2022 Aug 03, 2022	SELL	$26.4 - $30.54 $197,181 - $228,103	-7,469 Reduced 71.48%	2,980 $88,000
Q1 2022 May 02, 2022	SELL	$23.07 - $27.99 $418,674 - $507,962	-18,148 Reduced 63.46%	10,449 $274,000
Q3 2021 Oct 28, 2021	BUY	$23.37 - $32.13 $91,002 - $125,114	3,894 Added 15.76%	28,597 $712,000
Q2 2021 Aug 12, 2021	SELL	$18.78 - $25.15 $645,487 - $864,430	-34,371 Reduced 58.18%	24,703 $605,000
Q1 2021 Apr 26, 2021	BUY	$18.21 - $23.2 $885,169 - $1.13 Million	48,609 Added 464.49%	59,074 $0
Q4 2020 Feb 02, 2021	SELL	$15.39 - $22.1 $468,040 - $672,105	-30,412 Reduced 74.4%	10,465 $208,000
Q3 2020 Oct 14, 2020	SELL	$16.16 - $20.66 $644,202 - $823,590	-39,864 Reduced 49.37%	40,877 $677,000
Q2 2020 Jul 13, 2020	BUY	$13.31 - $19.41 $787,020 - $1.15 Million	59,130 Added 273.61%	80,741 $1.57 Million
Q1 2020 Apr 29, 2020	BUY	$13.06 - $21.24 $125,493 - $204,095	9,609 Added 80.06%	21,611 $311,000
Q4 2019 Feb 05, 2020	BUY	$17.29 - $21.74 $54,463 - $68,481	3,150 Added 35.59%	12,002 $244,000
Q3 2019 Oct 15, 2019	BUY	$19.51 - $24.28 $86,156 - $107,220	4,416 Added 99.55%	8,852 $172,000
Q2 2019 Jul 26, 2019	BUY	$21.47 - $37.33 $8,716 - $15,155	406 Added 10.07%	4,436 $99,000
Q1 2019 Apr 18, 2019	SELL	$28.4 - $36.49 $237,367 - $304,983	-8,358 Reduced 67.47%	4,030 $0
Q4 2018 Jan 16, 2019	BUY	$27.94 - $44.61 $346,120 - $552,628	12,388 New	12,388 $365,000
Q3 2018 Oct 23, 2018	SELL	$38.6 - $46.12 $101,479 - $121,249	-2,629 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$40.56 - $51.36 $106,632 - $135,025	2,629 New	2,629 $108,000
Q1 2018 Apr 26, 2018	SELL	$53.61 - $67.26 $2.54 Million - $3.18 Million	-47,300 Closed	0 $0
Q4 2017 Jan 10, 2018	BUY	$47.69 - $55.39 $1.9 Million - $2.2 Million	39,737 Added 525.41%	47,300 $2.59 Million
Q3 2017 Oct 25, 2017	BUY	$49.16 - $54.45 $371,797 - $411,805	7,563	7,563 $384,000

Others Institutions Holding ALKS

# of Institutions

362

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

Black Rock Inc. New York, NY

29.1M
Shares

$863 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$563 Million
0.01% of portfolio
Price T Rowe Associates Inc Baltimore, MD

13M
Shares

$385 Million
0.04% of portfolio
Wellington Management Group LLP Boston, MA

12.7M
Shares

$375 Million
0.06% of portfolio
State Street Corp Boston, MA

9.19M
Shares

$272 Million
0.01% of portfolio

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.87B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account